CBP-DWS is a 12-amino-acid linear polypeptide that specifically binds to colon cancer cells and tissues. CBP-DWS blocks the binding of anti-Glypican-3 antibodies to colon cancer cells with overexpressed Glypican-3. CBP-DWS can be used in research such as colon cancer imaging probes and targeted tracers for malignant tumors[1].
Molecular Weight:
1539.60
CAS Number:
[1840906-92-4]
Formula:
C70H94N18O22
Target:
Glycoprotein VI
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted